iShares Global Healthcare ETF (IXJ)
57.91
+0.14 +0.24%
NYSE Arca
Jun 15, 20:00
Delayed 2m
USD
IXJ Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
View All IXJ News
IXJ News
-
WireHeadlineTime (ET)
-
SA Breaking News06/08 08:02
-
SA Breaking News06/07 10:07
-
Yahoo05/09 10:31
-
Yahoo04/13 09:35
-
Yahoo04/04 10:33
-
SA Breaking News04/04 07:59
-
SA Breaking News04/02 08:10
-
Yahoo04/02 07:30
-
Yahoo04/02 07:30
-
Business Wire03/29 16:30
IXJ Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 2.77% | 2.69% | 5.13% | 95 |
| 3M | 0.44% | 0.38% | 3.87% | 85 |
| 6M | 2.33% | 2.58% | 10.43% | 91 |
| YTD | 2.93% | 2.93% | 10.18% | 91 |
| 1Y | 8.26% | 8.39% | 19.24% | 86 |
| 3Y | 3.93% | 3.99% | 5.13% | 56 |
| 5Y | 10.52% | 10.53% | 14.79% | 84 |
| 10Y | 10.60% | 10.51% | 13.63% | 90 |
IXJ Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.58% | 0.58% | 0.00% |
| Stock | 99.42% | 99.42% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
IXJ Region Exposure
| Americas | 70.89% |
| North America | 70.89% |
| Latin America | 0.00% |
| Greater Europe | 22.05% |
| United Kingdom | 4.41% |
| Europe Developed | 17.64% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 7.06% |
| Japan | 5.20% |
| Australasia | 1.86% |
| Asia Developed | 0.00% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
IXJ Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.00% |
| Healthcare | 99.12% |
| Industrials | 0.00% |
| Real Estate | 0.00% |
| Technology | 0.88% |
| Utilities | 0.00% |
IXJ Stock Market Capitalization
| Giant | 58.34% |
| Large | 36.50% |
| Medium | 5.15% |
| Small | 0.00% |
| Micro | 0.00% |
IXJ Stock Style Exposure
| Large Cap Value | 33.60% |
| Large Cap Blend | 29.56% |
| Large Cap Growth | 31.65% |
| Mid Cap Value | 1.06% |
| Mid Cap Blend | 1.94% |
| Mid Cap Growth | 2.19% |
| Small Cap Value | 0.00% |
| Small Cap Blend | 0.00% |
| Small Cap Growth | 0.00% |
View More Holdings
As of June 14, 2018
IXJ Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 6.78% | 122.61 | +0.16% |
| UNH | UnitedHealth Group Inc | 5.14% | 255.98 | +0.25% |
| PFE | Pfizer Inc | 4.43% | 36.36 | +0.55% |
| NOVN | Novartis AG | 4.14% | -- | -- |
| MRK | Merck & Co Inc | 3.43% | 62.03 | +0.76% |
| ABBV | AbbVie Inc | 3.28% | 99.57 | +0.83% |
| ROG | Roche Holding AG Dividend Right Cert. | 3.11% | -- | -- |
| AMGN | Amgen Inc | 2.57% | 185.01 | -0.42% |
| MDT | Medtronic PLC | 2.40% | 86.78 | +0.24% |
| ABT | Abbott Laboratories | 2.28% | 62.91 | -0.08% |
Advertisement
IXJ One Page Reports
- One Page Report Download
IXJ Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Benchmark Index | |
|---|---|
S&P Global 1200 Healthcare Sector NR USD |
100.0% |
IXJ Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 2.13 yrs |
| Diane Hsiung | 10.42 yrs |
| Greg Savage | 10.42 yrs |
| Jennifer Hsui | 5.84 yrs |
IXJ Net Fund Flows
| 1M | -31.00M |
| 3M | -65.14M |
| 6M | -52.82M |
| YTD | -75.39M |
| 1Y | -80.57M |
| 3Y | -211.40M |
| 5Y | 255.86M |
| 10Y | 315.49M |
IXJ Risk Info
| Beta (5Y) | 0.884 |
| Max Drawdown (All) | 40.60% |
| Historical Sharpe (10Y) | 0.7491 |
| Historical Sortino (All) | 0.6702 |
| 30-Day Rolling Volatility | 10.56% |
| Daily Value at Risk (VaR) 1% (All) | 3.00% |
| Monthly Value at Risk (VaR) 1% (All) | 11.55% |
IXJ Fundamentals
| Dividend Yield TTM (6-15-18) | 1.42% |
| SEC Yield (4-30-18) | 1.48% |
| Weighted Average PE Ratio | 25.63 |
| Weighted Average Price to Sales Ratio | 1.935 |
| Weighted Average Price to Book Ratio | 3.515 |
| Weighted Median ROE | 20.00% |
| Weighted Median ROA | 6.83% |
| Forecasted Dividend Yield | 2.10% |
| Forecasted PE Ratio | 15.79 |
| Forecasted Price to Sales Ratio | 1.841 |
| Forecasted Price to Book Ratio | 3.273 |
| Number of Holdings | 113 |
IXJ Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.77% |
| Forecasted Book Value Growth | 7.02% |
| Forecasted Cash Flow Growth | 8.00% |
| Forecasted Earnings Growth | -0.41% |
| Forecasted Revenue Growth | 7.57% |
IXJ Attributes
| Key Dates | |
|---|---|
| Inception Date | 11/13/2001 |
| Termination Date | |
| Last Annual Report Date | 3/31/2017 |
| Last Prospectus Date | 5/2/2018 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
IXJ Excel Add-In Codes
- Name: =YCI("IXJ","name")
- Broad Asset Class: =YCI("IXJ", "broad_asset_class")
- Broad Category: =YCI("IXJ", "broad_category_group")
- Prospectus Objective: =YCI("IXJ", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
